Seattle Children's Provider News

Practical Pediatrics: Improving Pediatric Practice (Category 1)

Saturday, Feb. 6, 7:30 a.m. to 3 p.m. (virtual)

Register now.

Learn more. Read full post »

Provider Grand Rounds: 

View full schedule and Webex/dial-in information. Topics and speakers may change. Call 206-987-5379 for updates or check our calendar online.

Feb. 4: SCD/Arginine Story. Klavano Holistic Care Lecture. Claudia R. Morris, MD, FAAP,
Professor of Pediatrics and Emergency Medicine; The Wilbur Fisk Glenn Jr. Distinguished Faculty Chair for Clinical and Translational Research; Research Director, Division of Pediatric Emergency Medicine; Co-Director, Center for Clinical and Translational Research, Emory University School of Medicine. Read full post »

Medical Providers

• Brian Ahuja, MD, Real Time Neuromonitoring Associates, Neurology
• Sarah Atkinson, MD, VA Puget Sound Medical Center, Neurology
• Lyubomyr Bohuta, MD, PhD, Seattle Children’s, Cardiac Surgery
• Jonathan Chen, MD, Real Time Neuromonitoring Associates, Neurology
• Vivian Hoang, MD, Seattle Children’s, Neurology
• Valerie Olson, MD, PhD, VA Puget Sound Medical Center, Neurology
• Daniel Vitantonio, MD, Seattle Children’s, Neurology

Read full post »

Dr. Danielle Zerr is medical director of infection prevention at Seattle Children’s.

Is vaccination underway at Seattle Children’s?

Dr. Zerr: Yes. We are pleased to say that Seattle Children’s began vaccinating its workforce for COVID-19 on Dec. 16, 2020. To date, we have received four shipments of the Pfizer vaccine (975 doses each) .  We expect the vaccine supply allocated to us by the Washington State Department of Health to arrive in weekly shipments. Like other healthcare systems in Washington, Seattle Children’s has limited information at this time about the types and quantities of vaccines we will receive in the near future. As we learn more, we will share.

We rely on information from the CDC’s Advisory Committee on Immunization Practices (ACIP) and state and local public health authorities to guide our decisions on safe and equitable distribution of our vaccine supply. Read full post »

Patients tested to date: 21,461. Positive: 536 (2.4%). Six patients are in the hospital; others are recovering at home.

During the COVID-19 pandemic, there has been a significant rise in the number and severity of patients with eating disorders. Given the high demand, Seattle Children’s Eating Disorders program is currently focusing our limited resources on patients who are medically unstable. We are prioritizing new visits for patients under the age of 18 who meet one of the following criteria:

• Heart rate < 60 bpm
• Weight loss of >10% over the past 3 months
• Abnormal laboratory work-up
• Abnormal EKG

Read full post »

Seattle Children’s is excited to announce the launch of a novel nonprofit research group that will accelerate the development of new medicines for childhood cancer and other debilitating pediatric diseases.

The new enterprise, Seattle Children’s Therapeutics, reimagines what a pediatric research organization should look like. It is intentionally structured like a biotech company rather than a typical academic research group. The people and functions needed to bring new medicines from bench to bedside — research scientists in the lab, clinical trials management teams, regulatory compliance specialists, business managers and a state-of-the-art on-site facility for manufacturing cellular and genetic therapeutics — have been brought together under one roof, under one management and leadership team.

Seattle Children’s Therapeutics includes a team of 130 led by Dr. Michael Jensen, Seattle Children’s chief therapeutics officer. A renowned pediatric cancer researcher and former founding scientist at Juno Therapeutics, Jensen says Seattle Children’s is “breaking the status quo” of pediatric disease research. Read full post »

Outpatient psychiatry services are now available at Seattle Children’s North Clinic in Everett. Providers at the North Clinic are offering:

• Diagnostic evaluations for depression, anxiety and early childhood disorders
• Stepped-care treatment for anxiety and externalizing behaviors (focusing on groups with some individual/family therapy)
• Parent management training
• Individual therapy for depressive disorders (very limited; by internal referral only)
• Treatment of young children focusing on parent management training

Read full post »

CDH is a complex disease that often requires lifelong follow-up care with many specialists. Children cared for by a multidisciplinary, integrated team have better outcomes and live healthier lives.

Seattle Children’s CDH program offers the best care and outcomes in the Northwest and is a destination center for families living in U.S. western states and abroad.   Read full post »

Significant mental health impacts on kids during the COVID-19 pandemic mean services like the Partnership Access Line (PAL) hotline are more important than ever. PAL supports the PCP community in treating their pediatric patients in several ways:

1. Specialized support in all areas of child and adolescent mental health to community prescribers that lack resources and cannot complete a care plan
2. Rapid access to in-person or telemedicine consultations for any child with Medicaid coverage; eligibility determined during a PAL call
3. Mental health resource support for PCPs and expansion resource support for families
4. Evidence-supported mental health training for primary care providers with Category 1 CME credit
5. Publishes Primary Care Principles for Child Mental Health manual containing evidence-supported care guidelines for treating providers

Read full post »